US DOJ appeals Texas ruling to halt abortion drug, mifepristone

Court Legal Proceedings

Posted by AI on 2025-08-26 08:30:22 | Last Updated by AI on 2025-08-26 11:02:29

Share: Facebook | Twitter | Whatsapp | Linkedin Visits: 0

---

The US Justice Department appealed a Texas court ruling from last week that would halt approval of the drug mifepristone, citing its "unprecedented" nature and stating that the Biden administration wants the ruling to remain on hold while they challenge it. A Trump-appointed judge issued an injunction ordering the FDA to halt approval of the drug, but the Biden administration and many abortion rights advocates argue that the ruling, which could take effect this week, could dramatically limit access to abortion in the US. The ruling is the latest development in what is becoming a labyrinth of legal challenges since the Supreme Court's decision to overturn Roe v. Wade.

The Biden administration, which has pledged to fight the lawsuit, argues that the Texas ruling "would severely harm women, particularly those for whom mifepristone is a medical or practical necessity." They also pointed out that there is "no precedent" for a single judge overruling the FDA's decision about safety and approval of medications.

Many abortion providers are awaiting further legal decisions before deciding how to navigate what is becoming a complex landscape for providers and patients. Some are prepared to pivot to different drug regimens or provide only surgical abortions if the Texas ruling takes effect this week.

The lawsuit, filed by the Alliance Defending Freedom, alleges that the FDA's initial approval of mifepristone was flawed and that the agency did not adequately review its safety risks. This lawsuit is one of many recent legal challenges that are dramatically reshaping the landscape of abortion access in the US.

Go!